Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Aarons

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 19, 1980
An improved HPLC assay for monitoring phenylbutazone and its two major oxidised metabolites in plasmaL Aarons, C Higham
IET Systems Biology|January 22, 2009
Proper lumping in systems biology modelsA Dokoumetzidis, L Aarons
Annals of the Rheumatic Diseases|April 1, 1984
Salicylate-NSAID interactionsD M Grennan, L Aarons
Journal of Pharmacokinetics and Biopharmaceutics|October 17, 1998
The pharmacokinetics of saquinavir: a Markov chain Monte Carlo population analysisD J Lunn, L Aarons
The Journal of Pharmacy and Pharmacology|October 1, 1989
A note on the use of salicylate saliva concentration in clinical pharmacokinetic studiesA Z Khan, L Aarons
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 6, 2000
Development of a sequential linked pharmacokinetic and pharmacodynamic simulation model for ivabradine in healthy volunteersS B Duffull, L Aarons
Journal of Theoretical Biology|September 22, 1989
Design and analysis of protein binding experimentsA Z Khan, L Aarons
Mental Retardation|April 1, 1988
Poetry recitation with persons who are mentally retardedL Aarons, E M Dixon
Pharmaceutical Research|May 1, 1989
Efficiency of drug targeting: steady-state considerations using a three-compartment modelA Boddy, L Aarons, K Petrak
Pharmaceutical Research|December 20, 1999
A pharmacokinetic model for tenidap in normal volunteers and rheumatoid arthritis patientsL Evans, L Aarons, P Coates
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 19, 1980
An improved HPLC assay for monitoring phenylbutazone and its two major oxidised metabolites in plasmaL Aarons, C Higham
IET Systems Biology|January 22, 2009
Proper lumping in systems biology modelsA Dokoumetzidis, L Aarons
Annals of the Rheumatic Diseases|April 1, 1984
Salicylate-NSAID interactionsD M Grennan, L Aarons
Journal of Pharmacokinetics and Biopharmaceutics|October 17, 1998
The pharmacokinetics of saquinavir: a Markov chain Monte Carlo population analysisD J Lunn, L Aarons
The Journal of Pharmacy and Pharmacology|October 1, 1989
A note on the use of salicylate saliva concentration in clinical pharmacokinetic studiesA Z Khan, L Aarons
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 6, 2000
Development of a sequential linked pharmacokinetic and pharmacodynamic simulation model for ivabradine in healthy volunteersS B Duffull, L Aarons
Journal of Theoretical Biology|September 22, 1989
Design and analysis of protein binding experimentsA Z Khan, L Aarons
Mental Retardation|April 1, 1988
Poetry recitation with persons who are mentally retardedL Aarons, E M Dixon
Pharmaceutical Research|May 1, 1989
Efficiency of drug targeting: steady-state considerations using a three-compartment modelA Boddy, L Aarons, K Petrak
Pharmaceutical Research|December 20, 1999
A pharmacokinetic model for tenidap in normal volunteers and rheumatoid arthritis patientsL Evans, L Aarons, P Coates
Pageof 11